St John's wort with SSRI and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — St John's wort may reduce apixaban exposure and increase serotonergic adverse-effect risk with fluoxetine.
St John's wort induces drug metabolism and transport pathways, which can reduce exposure to medicines such as some anticoagulants. It can also contribute to serotonergic adverse effects when combined with SSRIs. The patient should be advised not to self-start it and to seek prescriber review.
Reference: https://www.pharmacyregulation.org/students-and-trainees/pharmacist-education-and-training/registration-assessment